What Is the Best GLP-1 Medication for Weight Loss in 2026?
Last updated: January 2026
Quick Answer
Tirzepatide (Zepbound/Mounjaro) produces the highest average weight loss at 20-22%, followed by semaglutide (Wegovy) at 15%.
What Is the Best GLP-1 Medication for Weight Loss in 2026
Tirzepatide (Zepbound/Mounjaro) produces the highest average weight loss at 20-22%, followed by semaglutide (Wegovy) at 15%.
Understanding how GLP-1 medications work, their differences, and what to expect during treatment helps you make informed decisions about your weight loss journey. These medications represent a breakthrough in obesity treatment, with clinical trial results that far exceed previous weight loss interventions.
Key Facts
- GLP-1 medications are FDA-approved and backed by large-scale clinical trials
- Semaglutide and tirzepatide are the two most commonly prescribed GLP-1 medications for weight loss
- Both are administered as weekly subcutaneous injections using easy-to-use pen devices
- Treatment starts at a low dose and gradually increases over 16-20 weeks
- Most patients experience significant appetite reduction within the first week
Choosing the Right Medication
Your healthcare provider will help determine which GLP-1 medication is best for your specific situation based on your health conditions, weight loss goals, insurance coverage, and budget. Both semaglutide and tirzepatide are highly effective options.